Evidence map›Paper›PMID 32569542›Full record

ArticleSubstance use & misuse2020

Betel Quid, Health, and Addiction.

Roger L Papke, Dorothy K Hatsukami, Thaddeus A Herzog

Registry-linked trialAbstract read
In one paragraph

Article in Substance use & misuse, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05782166 (Cross-Cultural Adaptation of a Betel Quid Cessation Program and Evaluation of Its Effectiveness in a Malaysian High-Risk Community), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05782166 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Cross-Cultural Adaptation of a Betel Quid Cessation Program and Evaluation of Its Effectiveness in a Malaysian High-Risk Community

TypeinterventionalSponsorUniversity of MalayaRan2024 to 2024Enrolled92ConditionsBetel Nut Chewer, Tobacco CessationArmsBetel Quid Educational Booklet, Betel Quid Cessation Intervention Module
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. A Review of Intervention Strategies for Areca Nut Use Cessation.Indian journal of psychological medicine · 2023
    Review
  5. Article
  6. Therapeutic Targeting ofPharmacological reviews · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Roger L PapkeDepartment of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, Florida, USA.ORCID 0000-0002-4468-8658
Dorothy K HatsukamiDepartment of Psychiatry and the Masonic Cancer Center, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Thaddeus A HerzogUniversity of Hawaii Cancer Center, Honolulu, Hawaii, USA.

Funding

University of Guam/Cancer Research Center of Hawaii Partnership (1 of 2)U54CA143727 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI THADDEUS A HERZOG · 2009 to 2026
$19.1M
Targeting of Alpha7 nAChR for therapeutic effectsR01GM057481 · NIGMS · UNIVERSITY OF FLORIDA · PI PAPKE, ROGER L · 2000 to 2023
$7.6M
NCI NIH HHS U54 CA143727NIGMS NIH HHS R01 GM057481
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ArecaBehavior, AddictiveHumansaddictionArecabetel quidcancernicotine

Identifiers

PMID32569542
PMCPMC7737392

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.